Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2003-5-16
pubmed:abstractText
The human DF3/MUC1 transmembrane protein is aberrantly expressed in multiple myeloma cells and other B cell malignancies. The regulation of MUC1 in B cells and its potential function as a signaling molecule are unknown. The present results demonstrate that interleukin-7 (IL-7) stimulates MUC1 expression in multiple myeloma cells. The results also demonstrate the IL-7 induces binding of MUC1 to the Lyn tyrosine kinase. The MUC1 C-terminal subunit binds directly to Lyn through interactions with the Lyn SH3 and SH2 domains. Activation of Lyn in response to IL-7 stimulation results in increased tyrosine phosphorylation of the MUC1 C-terminal subunit. In vitro and in vivo studies show that Lyn phosphorylates MUC1, at least in large part, on a YEKV site in the MUC1 cytoplasmic tail. The functional significance of the MUC1-Lyn interaction is supported by the demonstration that Lyn-mediated phosphorylation of MUC1 on YEKV induces binding of MUC1 and the beta-catenin signaling protein. In concert with these results, IL-7 treatment is associated with binding of MUC1 to beta-catenin and targeting of the MUC1-beta-catenin complex to the nucleus. These findings indicate that IL-7 regulates MUC1 expression and function in multiple myeloma cells.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1538-4047
pubmed:author
pubmed:issnType
Print
pubmed:volume
2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
187-93
pubmed:dateRevised
2011-11-2
pubmed:meshHeading
pubmed-meshheading:12750561-Amino Acid Sequence, pubmed-meshheading:12750561-Cytoskeletal Proteins, pubmed-meshheading:12750561-DNA Primers, pubmed-meshheading:12750561-Fluorescent Antibody Technique, pubmed-meshheading:12750561-Humans, pubmed-meshheading:12750561-Immunoblotting, pubmed-meshheading:12750561-Interleukin-7, pubmed-meshheading:12750561-Molecular Sequence Data, pubmed-meshheading:12750561-Mucin-1, pubmed-meshheading:12750561-Multiple Myeloma, pubmed-meshheading:12750561-Phosphorylation, pubmed-meshheading:12750561-Polymerase Chain Reaction, pubmed-meshheading:12750561-Precipitin Tests, pubmed-meshheading:12750561-Protein Binding, pubmed-meshheading:12750561-Recombinant Proteins, pubmed-meshheading:12750561-Signal Transduction, pubmed-meshheading:12750561-Trans-Activators, pubmed-meshheading:12750561-Transfection, pubmed-meshheading:12750561-Tumor Cells, Cultured, pubmed-meshheading:12750561-Tyrosine, pubmed-meshheading:12750561-beta Catenin, pubmed-meshheading:12750561-src-Family Kinases
pubmed:articleTitle
DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7.
pubmed:affiliation
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.